UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | J | K | L | M | N | O | P | S | T | U | V | W
Number of items: 105.

A

Ah-See, MW; Makris, A; Taylor, NJ; Harrison, M; Ostler, PJ; Richman, PI; Stirling, JJ; ... Padhani, A; + view all (2004) Changes in dynamic contrast-enhanced MRI as an early predictor of response to neoadjuvant chemotherapy in primary breast cancer. British Journal of Cancer , 91 S22-S22.

Ah-See, MW; Padhani, AR; Taylor, NJ; Daley, FM; Bentzen, SM; Burcombe, RJ; Harrison, M; ... Makris, A; + view all (2004) Tumour microvasculature, assessment by dynamic contrast- enhanced MRI fails to correlate with VEGF expression in breast cancer biopsies. British Journal of Cancer , 91 S16-S16.

Akbar, AN; Beverley, PCL; Salmon, M; (2004) Opinion - Will telomere erosion lead to a loss of T-cell memory? NAT REV IMMUNOL , 4 (9) 737 - 743. 10.1038/nri1440.

Arkenau, HT; Porschen, R; (2004) Adjuvant chemotherapy in curative resected colon carcinoma. Verdauungskrankheiten , 22 (4) pp. 208-215.

Arkenau, HT; Porschen, R; (2004) Adjuvante Therapie des kolorektalen Karzinoms. Verdauungskrankheiten pp. 208-215.

B

BBC, NO; (2004) Drug boosts lung cancer survival. UNSPECIFIED

BBC, NORCR; (2004) 'They just didn't know what it would do'. UNSPECIFIED

BBC News at Ten BBC news correspondent, AM; (2004) Passive smoking is a public health hazard. UNSPECIFIED

BBC News at Ten BBC news correspondent, AM; (2004) Smart drug for lung cancer tested. UNSPECIFIED

Barber, L.J.; (2004) The Saccharomyces cerevisiae Snm1 gene and repair of anticancer drug-induced DNA interstrand cross-links. Doctoral thesis , University of London. Green open access
file

Bentzen, SM; Bernier, J; Khalil, AA; Saunders, MI; Horiot, JC; Van den Bogaert, W; Cummings, BJ; (2004) Estimatet effect of patient non-compliance to dose-time constraints in five randomized clinical trials of altered fractionation in radiotherapy for head-and-neck carcinomas. Strahlentherapie und Onkologie , 180 p. 98.

Birtle, AJ; Newby, JC; Harland, SJ; (2004) Epirubicin carboplatin and 5-fluorouracil (ECarboF) chemotherapy in metastatic hormone refractory prostate cancer. British Journal of Cancer , 91 (8) pp. 1472-1476.

Bower, M; Stebbing, J; Thirlwell, C; Newsom-Davis, T; Waterston, A; Mandalia, S; Gazzard, B; (2004) Anti-retroviral treatment regimens and immune parameters in the prevention of systemic HIV-related non-Hodgkin's lymphoma. In: JOURNAL OF CLINICAL ONCOLOGY. (pp. 105S - 105S). AMER SOC CLINICAL ONCOLOGY

Bower, M; Stebbing, J; Thirlwell, C; Newsom-Davis, T; Waterston, A; Mandalia, S; Gazzard, B; (2004) Anti-retroviral treatment regimens and immune parameters in the prevention of systemic HIV-related non-Hodgkin's lymphoma. J Clin Oncol , 22 (14_suppl) 1034-.

Bownes, P; Hoskin, PJ; Ostler, PJ; Lowe, GJ; Bryant, L; (2004) Quality assurance for fractionated high dose rate afterloading brachytherapy as monotherapy for prostate cancer. Radiotherapy and Oncology , 71 241-.

Burroughs, A; Hochhauser, D; Meyer, T; (2004) Systemic treatment and liver transplantation for hepatocellular carcinoma: two ends of the therapeutic spectrum. LANCET ONCOL , 5 (7) 409 - 418.

C

Calvert, AH; (2004) Biochemical pharmacology of pemetrexed. Oncology (Williston Park) , 18 (13 Suppl) pp. 13-17.

Cansick, JC; Lennon, R; Cummins, CL; Howie, AJ; McGraw, ME; Saleem, MA; Tizard, EJ; ... Taylor, CM; + view all (2004) Prognosis, treatment and outcome of childhood mesangiocapillary (membranoproliferative)glomerulonephritis. Nephrology Dialysis Transplantation , 19 pp. 2769-2777.

Channel, 4IMF; (2004) Happy Birthday Thalidomide. UNSPECIFIED

Chester, JD; Hall, GD; Forster, M; Protheroe, AS; (2004) Systemic chemotherapy for patients with bladder cancer - current controversies and future directions. CANCER TREATMENT REVIEWS , 30 (4) pp. 343-358. 10.1016/j.ctrv.2003.12.005.

Chester, K; Pedley, B; Tolner, B; Violet, J; Mayer, A; Sharma, S; Boxer, G; ... Begent, R; + view all (2004) Engineering antibodies for clinical applications in cancer. Tumor Biology , 25 (1-2) pp. 91-98.

Clingen, PH; Wu, J; Prise, KM; Hartley, JA; (2004) H2AX nuclear foci are induced in human cells after treatment with DNA interstrand crosslinking chemotherapeutics. BRITISH JOURNAL OF CANCER , 91 S48 - S48.

D

Dumez, H; Van Oosterom, AT; Rothermel, JD; Mull, R; Calvert, AH; (2004) Phase Ib/II dose-escalation trial evaluating the safety and tolerability of EPO906 plus capecitabine in patients with advanced cancer. J Clin Oncol , 22 (14_suppl) 2093-.

Dumez, H; Van Oosterom, AT; Rothermel, JD; Mull, R; Calvert, AH; (2004) Phase Ib/Il dose-escalation trial evaluating the safety and tolerability of EP0906 plus capecitabine in patients with advanced cancer. Journal of Clinical Oncology , 22 (14) 2093-.

E

Eardley, KS; Ferreriera, MAS; Howie, AJ; Gosling, P; Lipkin, GW; (2004) Urinary albumin excretion: a predictor of glomerular findings in microscopic haematuria. QJM , 97 pp. 297-301.

F

Ffolkes, LV; Freeman, A; Harland, SJ; Parkinson, MC; (2004) Are there diagnostic problems with testis tumours? JOURNAL OF PATHOLOGY , 204 35A - 35A.

Forster, MD; Madhusudan, S; Muthuramalingam, SR; Braybrooke, JP; Wilner, S; Kaur, K; Han, C; ... Harris, AL; + view all (2004) A phase II Study of Etanercept (Enbrel), a Tumor Necrosis Factor alpha Inhibitor in Patients with Metastatic Breast Cancer. Clin Cancer Res. , 10 (19) pp. 6528-6534.

Foster, C; Evans, DGR; Eeles, R; Eccles, D; Ashley, S; Brooks, L; Cole, T; ... Watson, M; + view all (2004) Non-uptake of predictive genetic testing for BRCA1/2 among relatives of known carriers: Attributes, cancer worry, and barriers to testing in a multicenter clinical cohort. Genetic Testing , 8 (1) pp. 23-29.

Francis, RJ; Mather, SJ; Chester, K; Sharma, SK; Bhatia, J; Pedley, RB; Waibel, R; ... Begent, RHJ; + view all (2004) Radiolabelling of glycosylated MFE-23 :: CPG2 fusion protein (MFECP1) with Tc-99m for quantitation of tumour antibody-enzyme localisation in antibody-directed enzyme pro-drug therapy (ADEPT). EUR J NUCL MED MOL I , 31 (8) 1090 - 1096. 10.1007/s00259-004-1474-4.

G

Gasco, M; Sullivan, A; Smith, P; Farrell, P; Numico, G; Colantonio, I; Merlano, M; (2004) Transcriptional silencing of Fanconi anaemia genes and clinical outcome in head and neck cancer. J Clin Oncol , 22 (14_suppl) 9546-.

Geary, J; Hodgson, SV; Homfray, T; Mackay, J; Izatt, L; Dorkins, H; Thomas, H; ... Eeles, R; + view all (2004) HNPCC - Where does the buck stop? Journal of Medical Genetics , 41 S36-S36.

Giampieri, S; Storey, A; (2004) Repair of UV-induced thymine dimers is compromised in cells expressing the E6 protein from humanpapillomaviruses types 5 and 18. BRIT J CANCER , 90 (11) 2203 - 2209. 10.1038/sj.bjc.6601829.

H

Hallowell, N; Mackay, J; Richards, M; Gore, M; Jacobs, I; (2004) High-risk premenopausal women's experiences of undergoing prophylactic oophorectomy: A descriptive study. Genetic Testing , 8 (2) pp. 148-156.

Harney, J; Shah, N; Short, S; Daley, F; Groom, N; Wilson, GD; Joiner, MC; (2004) The evaluation of low dose hyper-radiosensitivity in normal human skin. Radiotherapy and Oncology , 70 (3) pp. 319-329. 10.1016/j.radonc.2004.01.015.

Harney, J; Short, S; Shah, N; Joiner, M; Saunders, MI; (2004) Low dose hyper-radiosensitivity in metastatic tumors. International Journal of Radiation Oncology Biology Physics , 59 (4) pp. 1190-1195. 10.1016/j.ijrobp.2003.12.029.

Hartley, JA; (2004) Assessing individual responses to anti-cancer therapy using the comet assay. Mutagenesis , 19 (6) 15-.

Hartley, JA; (2004) Assessing individual responses to anti-cancer therapy using the comet assay. MUTAGENESIS , 19 (6) 504 - 504.

Helena Selby, BBCWSABBCR4; (2004) BBC World Service Health Matters Programme on Lung Cancer. UNSPECIFIED

Hoskin, PJ; (2004) The RIB trial. Clinical Oncology , 16 (7) pp. 445-446.

Hoskin, PJ; (2004) Should all breast cancer patients with symptomatic bone metastasis be treated with bisphosphonates? The case against. Clinical Oncology , 16 (2) pp. 112-114.

Hoskin, PJ; Decanha, SM; P, G-J; R, ; (2004) High dose rate afterloading intraluminal brachytherapy for advanced inoperable rectal carcinoma. Radiotherapy and Oncology , 73 pp. 195-198.

Hoskin, PJ; Sibtain, A; Daley, FM; Saunders, MI; Wilson, GD; (2004) The immunohistochemical assessment of hypoxia, vascularity and proliferation in bladder carcinoma. Radiotherapy and Oncology , 72 (2) pp. 159-168.

Howie, AJ; (2004) Defining the role of pathology services in the diagnosis and staging of renal cell carcinoma. In: Aitchison, M and Oliver, RTD and Miles, A, (eds.) The Effective Management of Renal Cell Carcinoma. (pp. 49-53). Aesculapius Medical Press: London.

Howie, AJ; Adu, D; (2004) Different meanings of 'glomerular tip lesion'. Kidney International , 66 1716-.

Howie, AJ; Ferreira, MAS; Lipkin, GW; Adu, D; (2004) Measurement of chronic damage in the donor kidney and graft survival. Transplantation , 77 pp. 1058-1065. 10.1097/01.TP.0000120177.44144.FF.

Huhalov, A; Spencer, DIR; Chester, KA; (2004) A strategy for characterizing antibody/antigen interactions using proteinchip arrays. In: Conn, PM, (ed.) Handbook of proteomic methods. (pp. 117-128). Humana Press: New Jersey.

Huhalov, A.; (2004) Design and cancer-targeting potential of antibody-based molecules directed against carcinoembryonic antigen. Doctoral thesis , University of London. Green open access
file

J

Jia, L; Spanswick, VJ; Reid, JM; Kuffel, M; Buhrow, SA; Ames, MM; Hartley, JA; ... Tomaszewski, JE; + view all (2004) Use of the comet assay as a surrogate biomarker for the in vivo measurement of DNA damage to lymphocytes. Proceedings of the American Association for Cancer Research , 45 1969-.

K

Kakkar, AK; Bundred, N; Carpenter, R; Makris, A; Merriman, H; Walker, ID; (2004) Venous thromboembolism in cancer patients. Guidelines. EGUIDELINES , 23 pp. 311-314.

Kalra, D; Singleton, P; Ingram, D; Milan, J; MacKay, J; Detmer, D; Rector, A; (2004) Security and confidentiality approach for the Clinical E-ScienceFramework (CLEF). In: (Proceedings) Health Grid 2004. : Clermont-Ferrand, France.

Kiakos, K; Hartley, JA; Price, C; Lingerfelt, B; Handl, H; Lee, M; (2004) Design, synthesis and DNA alkylation specificity of novel achiral seco-CI-polyamide hairpin conjugates. Proceedings of the American Association for Cancer Research , 45 3091-.

Kiakos, K; Mchugh, PJ; Hartley, JA; Sato, K; Summerville, K; C, L; M, ; (2004) Design, synthesis and biological evaluation of AS-I-145, a novel achiral amino seco-CBI. Proceedings of the American Association for Cancer Research , 45 3998-.

Kim, JB; O'Hare, MJ; Stein, R; (2004) Models of breast cancer: is merging human and animal models the future? BREAST CANCER RESEARCH , 6 (1) pp. 22-30. 10.1186/bcr645.

Kupchinsky, S; Centioni, S; Howard, T; Trzupek, J; Roller, S; Carnahan, V; Townes, H; ... Lee, M; + view all (2004) A novel class of achiral seco-analogs of CC-1065 and the duocarmycins: design, synthesis, DNA binding, and anticancer properties. Bioorganic and Medicinal Chemistry , 12 (23) pp. 6221-6236.

L

Le Pla, RC; Landreau, CAS; Shipman, M; Slawin, AMZ; Hartley, JA; (2004) The role of the naphthoate moiety and its substituents upon the efficiency of DNA interstrand cross-linking by the azinomycins. Mutagenesis , 19 (6) 51-.

Le Pla, RC; Landreau, CAS; Shipman, M; Slawin, AMZ; Hartley, JA; (2004) The role of the naphthoate moiety and its substituents upon the efficiency of DNA interstrand cross-linking by the azinomycins. MUTAGENESIS , 19 (6) 516 - 516.

Litchfield, TM; Gilchrist, S; Sunderland, R; Folkard, M; Short, S; Prise, K; (2004) A three dimensional tissue culture model for microbeam studies. In: (pp. P 462.4-).

Liu, WM; Strauss, SJ; Chaplin, T; Shahin, S; Propper, DJ; Young, BD; Joel, SP; (2004) s-thalidomide has a greater effect on apoptosis than angiogenesis in a multiple myeloma cell line. Hematol J , 5 (3) 247-54-247-54.

M

Makris, A; (2004) Critical commentary of: HER-2/neu gene amplification and response to paclitaxel in patients with metastatic breast cancer. Women's Oncology Review , 4 pp. 277-278.

Makris, A; (2004) Critical commentary of: Quantitative DNA fingerprinting may distinguish new primary breast cancer from disease recurrence. Women's Oncology Review , 4 pp. 213-214.

Makris, A; Glynne-Jones, R; Sebag-Montefiore, D; Samuel, L; Myint, S; Levine, E; Martin, A; (2004) Compliance to chemotherapy with oxaliplatin and 5fluorouracil in patients with advanced rectal cancer who rave received prior high-dose pelvic radiotherapy. British Journal of Cancer , 91 S34-S34.

Mayer, A; Francis, R; Sharma, SK; Sully, C; Parker, S; Tolner, B; Griffin, N; ... Begent, RHJ; + view all (2004) A phase I/II trial of antibody directed enzyme prodrug therapy (ADEPT) with MFECP1 and ZD2767P. British Journal of Cancer , 91 S8-S8.

McGurk, CJ; Cummings, M; Hartley, JA; Masters, JR; (2004) Translational regulation of ERCC1 in human cancer cell lines. Proceedings of the American Association for Cancer Research , 45 2631-.

McMeish, I; Kanfer, EJ; Haynes, R; Giles, C; Harland, SJ; Driver, D; Rustin, GJS; ... Seckl, MJ; + view all (2004) Paclitaxel-containing high-dose chemotherapy for relapsed or refractory testicular germ cell tumours. British Journal of Cancer , 90 (6) pp. 1169-1175.

McTiernan, A; Whelan, JS; (2004) A Phase II Study of Docetaxel for the Treatment of Recurrent Osteosarcoma. Sarcoma , 8 (2-3) pp. 71-76. 10.1080/13577140410001711764. Gold open access

Mchugh, PJ; Hartley, JA; (2004) Repair of DNA interstrand crosslinks Produced by Cancer Chemotherapeutic Drugs. In: Panasci, LC and Alaoui-Jamali, MA, (eds.) DNA Repair in Cancer Therapy. (pp. 31-49). Humana Press: Totowa. NJ.

Melichar, B; Casado, E; Tabemero, J; Hosseinzadeh, S; Hamm, J; Wadler, S; Bridgewater, J; ... Johri, A; + view all (2004) Phase I dose optimization trial of patupilone in previously treated patients (pts) with advanced colon cancer. In: (pp. p. 85). OXFORD UNIV PRESS

N

Novak-Hofer, I; Waibel, R; Zimmermann, K; Schibli, R; Grünberg, ; J, ; Chester, ; ... P, A; + view all (2004) Radiometal labeling of antibodies and antibody fragments for imaging and therapy. In: Methods Mol Biol. (pp. 481-494). Humana Press

O

O'Donnell, A; Judson, I; Dowsett, M; Raynaud, F; Dearnaley, D; Mason, M; Harland, S; ... Jarman, M; + view all (2004) Hormonal impact of the 17 alpha-hydroxylase/C-17,C-20-lyase inhibitor abiraterone acetate (CB7630) in patients with prostate cancer. British Journal of Cancer , 90 (12) pp. 2317-2325.

Okkenhaug, K; Bilancio, A; Emery, JL; Vanhaesebroeck, B; (2004) Phosphoinositide 3-kinase in T cell activation and survival. Circulation Research , 95 (4) pp. 380-388.

P

Parker, LL; Lacy, SM; Farrugia, LJ; Evans, C; Robins, DJ; O'Hare, CC; Hartley, JA; ... Stratford, IJ; + view all (2004) A novel design strategy for stable metal complexes of nitrogen mustards as bioreductive prodrugs. J MED CHEM , 47 (23) 5683 - 5689. 10.1021/jm0449866w.

Pedley, RB; Sharma, SK; Hawkins, RE; Chester, KA; (2004) Antibody-directed enzyme-prodrug therapy. In: UNSPECIFIED (pp. 491-514).

Pedley, RB; Sharma, SK; Hawkins, RE; Chester, KA; (2004) Antibody-directed enzyme-prodrug therapy. In: UNSPECIFIED (pp. 491-514).

Peltenburg, LTC; de Bruin, EC; Meersma, D; Wilting, S; Jürgensmeier, JM; Schrier, PI; (2004) c-Myc is able to sensitize human melanoma cells to diverse apoptotic triggers. Melanoma Res , 14 (1) pp. 3-12.

S

Saunders, MI; Rojas, AM; (2004) Management of cancer of the head and neck--a cocktail with your PORT? N Engl J Med , 350 (19) pp. 1997-1999. 10.1056/NEJMe048038.

Short, S; (2004) UNSPECIFIED In: (Proceedings) ESTRO 23, Amsterdam.

Short, SC; Suovuori, A; Cook, G; Vivian, G; Harmer, C; (2004) A phase II study using retinoids as redifferentiation agents to increase iodine uptake in metastatic thyroid cancer. Clinical Oncology , 16 (8) pp. 569-574.

Short, SM; Makris, A; Jones, RG; Novell, R; Harrison, M; (2004) Low dose continuous hyperfractionated accelerated radiation therapy (CHART) as preoperative treatment for rectal carcinoma. British Journal of Cancer , 91 S38-S38.

Sibtain, A; Saunders, MI; Bentzen, SM; Hoskin, PJ; (2004) Pre-treatment haemoglobin concentration in accelerated and conventional radiotherapy for non-small cell lung carcinoma. Clinical Oncology , 16 (1) pp. 58-62.

Sky, NRJJ; (2004) Cost issues behind government health reforms. UNSPECIFIED

Soares, MVD; Plunkett, FJ; Verbeke, CS; Cook, JE; Faint, JM; Belaramani, LL; Fletcher, JM; ... Akbar, AN; + view all (2004) Integration of apoptosis and telomere erosion in virus-specific CD8(+) T cells from blood and tonsils during primary infection. BLOOD , 103 (1) 162 - 167. 10.1182/blood-2003-06-1791.

Stewart, G; Lee, SM; (2004) Poor performance status patients and the TOPICAL Trial. Lung Cancer in Practice , 1 (3) pp. 1-3.

Stewart, M; Daniell, K; Madsen, E; Le, M; Handl, H; Brooks, N; Kiakos, K; ... Lee, M; + view all (2004) Novel class of duocarmycin analogs: Design, synthesis and biological evaluation of achiral analogs of duocarmycin SA. In: (pp. U29-U29).

Strauss, SJ; McTiernan, A; Whelan, JS; (2004) Late relapse of osteosarcoma: Implications for follow-up and screening. PEDIATR BLOOD CANCER , 43 (6) 692 - 697. 10.1002/pbc.20154.

Swanton, C; Johnston, S; (2004) New Targets and Innovative Strategies in Cancer Treatment: one year of progress. 13-14 February 2004, Nice, France. IDrugs , 7 (4) pp. 306-311.

T

T M Litchfield, G; S, S; R, F; M, S; S, P; K, ; (2004) UNSPECIFIED In: (Proceedings) Society for Neuroscience 34th Annual Meeting.

Taghian, A; Jagsi, R; Makris, A; Goldberg, S; Ceilley, E; Grignon, L; Powell, S; (2004) Results of a survey regarding irradiation of internal mammary chain in patients with breast cancer: Practice is culture driven rather than evidence based. International Journal of Radiation Oncology Biology Physics , 60 (3) pp. 706-714.

Taylor, CM; Chua, C; Howie, AJ; Risdon, RA; (2004) Clinico-pathological findings in haemolytic uraemic syndrome not associated with diarrhoea. Pediatric Nephrology , 19 pp. 419-425.

Thomas, R; Godward, S; Makris, A; Bloomfield, D; Moody, AM; Williams, M; (2004) Giving patients a choice improves quality of life: A multi- centre, investigator-blind, randomised, crossover study comparing letrozole with anastrozole. Clinical Oncology , 16 (7) pp. 485-491.

Tikhe, JG; Webber, SE; Hostomsky, Z; Maegley, KA; Ekkers, A; Li, JK; Yu, XH; ... Newell, DR; + view all (2004) Design, synthesis, and evaluation of 3,4-dihydro-2H-[1,4]diazepino[6,7,1-hi]indol-1-ones as inhibitors of poly(ADP-ribose) polymerase. J MED CHEM , 47 (22) 5467 - 5481. 10.1021/jm030513r.

Twelves, C; Gokul, S; Jones, RH; Boddy, A; Macham, M; Fishwick, K; Wheaton, J; ... Calvert, AH; + view all (2004) Phase I study to evaluate the safety, tolerability and pharmacokinetics of OSI-211 (Liposomal Lurtotecan) in combination with Carboplatin. ANN ONCOL , 15 105 - 105.

U

Urbaniak, MD; Bingham, JP; Hartley, JA; Woolfson, DN; Caddick, S; (2004) Improved Stability of Nitrogen-Mustard Derivatives Using apo-Neocarzinostatin. Journal of Medicinal Chemistry , 47 pp. 4710-4715.

V

Van Zuylen, L; Bridgewater, J; Sparreboom, A; Eskens, FALM; De Bruijn, P; Sklenar, I; Planting, AST; ... Verweij, J; + view all (2004) Phase I and Pharmacokinetic Study of the Polyamine Synthesis Inhibitor SAM486A in Combination with 5-Fluorouracil/Leucovorin in Metastatic Colorectal Cancer. Clinical Cancer Research , 10 (6) pp. 1949-1955. 10.1158/1078-0432.CCR-02-0995.

Vanhaesebroeck, B; Rohn, JL; Waterfield, MD; (2004) Gene targeting: Attention to detail. CELL , 118 (3) pp. 274-276. 10.1016/j.cell.2004.07.018.

Vanhaesebroeck, B; Rohn, JL; Waterfield, MD; (2004) Gene targeting: attention to detail. Cell , 118 (3) pp. 375-387.

Vassileva, VT; (2004) Release profile characterization of a novel Implantable paclitaxel loaded lipid polymer system in CD-1 mice. In: (Proceedings) American Association of Pharmaceutical Scientists Annual Meeting and Exposition.

Venables, K; Miles, EA; Aird, EGA; Hoskin, PJ; (2004) The use of in vivo thermoluminescent dosimeters in the quality assurance programme for the START breast fractionation trial. Radiotherapy and Oncology , 71 (3) pp. 303-310.

Venables, K; Miles, EA; Deighton, A; Aird, EGA; Hoskin, PJ; (2004) Irradiation of the heart during tangential breast treatment: a study within the START trial. British Journal of Radiology , 77 (914) pp. 137-142.

van Zuylen, L; Bridgewater, J; Sparreboom, A; Eskens, FALM; de Bruijn, P; Sklenar, I; Planting, AST; ... Verweij, J; + view all (2004) Phase I and pharmacokinetic study of the polyamine synthesis inhibitor SAM486A in combination with 5-fluorouracil/leucovorin in metastatic colorectal cancer. CLIN CANCER RES , 10 (6) 1949 - 1955.

W

Wallace, E; Hinds, A; Campbell, H; Mackay, J; Cetnarskyj, R; Porteous, ME; (2004) A cross-sectional survey to estimate the prevalence of family history of colorectal, breast and ovarian cancer in a Scottish general practice population. British Journal of Cancer , 91 (8) pp. 1575-1579.

Waterston, A; Thirlwell, C; Newsom-Davis, T; Powles, T; Nelson, M; Gazzard, B; Bower, M; (2004) Does highly active antiretroviral therapy (HAART) affect the incidence or outcome of invasive anal cancer? In: BRITISH JOURNAL OF CANCER. (pp. S13 - S13). NATURE PUBLISHING GROUP

Whelan, J; (2004) Late Effects of Childhood Cancer. Lancet Oncology

Whelan, JS; McTiernan, A; (2004) for the London Bone and Soft Tissue Tumour Service. A prospective study of pre-operative chemotherapy with single agent ifosfamide for malignant fibrous histiocytoma of bone. Sarcoma , 8 pp. 77-82. Gold open access

Whelan, JS; McTiernan, AM; Strauss, SJ; (2004) Single centre experience of a new intensive induction therapy for Ewing’s family of tumours using Holoxan in the VIDE regimen. Final results and conclusions. In:

Whelan, JS; Morland, B; (2004) Bone Tumours. In: Pinkerton, CR and Plowman, P, (eds.) Paediatric Oncology. Clinical Practice and Controversies. : London.

This list was generated on Sun May 20 01:52:35 2018 BST.